Biotech firm Revvity ( RVTY) posted first-quarter results that topped analysts' estimates. The company on Monday reported ...

A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech ...

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had ...

On Thursday, an analyst launched coverage of Edgewise Therapeutics (NASDAQ: EWTX) stock, and the market took notice in a good ...

Q1 2025 Earnings Call Transcript May 6, 2025 Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $1.2 EPS, expectations were $1.38. Operator: Thank you for standing by, and welcome ...

Krystal Biotech KRYS reported first-quarter 2025 earnings ... is currently developing a décolleté-specific photo numeric scale for advanced clinical development of KB301. This subsidiary expects ...

Krystal Biotech KRYS reported first-quarter 2025 earnings per share (EPS) of $1.20, which missed the Zacks Consensus Estimate ...

Thank you for standing by, and welcome to the Krystal Biotech First Quarter 2025 Earnings Call. At this time, all participants are on a listen-only mode. After the speakers' presentations, there will ...

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2025 and provided a business ...

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS ... is currently developing a décolleté-specific photo numeric scale for advanced clinical development of KB301.

The lustrous, metallic allure of gold has long fueled intrigue and in recent months its market fortunes have also reflected ...